Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| STERIS plcSTE · Entity 3228 | V.P., Human Resources & CHRO | March 28, 2019 | June 27, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
STERIS plc
Report date March 28, 2019 · Filed June 27, 2019 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | IndirectSee Footnote Below. | 30 |
Reported balance
After 2019-03-28 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2019-03-28 · Grant · Acquired 30 · Balance 30 F1: The Reporting Person failed to report ordinary share equivalents held in the STERIS Corporation 401k Plan. A corresponding failure to report was made in the Reporting Person's Form 4 filing made March 28, 2019 with respect to Old STERIS (as hereinafter defined). F2: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), received by the Reporting Person pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the Reporting Person received shares of STERIS in an amount equal to the number of the Reporting Person's cancelled shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"). The Reporting Person's STERIS shares are subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares, except as otherwise required by law. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. F3: Represents 30 ordinary share equivalents held on behalf of the Reporting Person under the STERIS Corporation 401(k) Plan as of March 28, 2019. |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person failed to report ordinary share equivalents held in the STERIS Corporation 401k Plan. A corresponding failure to report was made in the Reporting Person's Form 4 filing made March 28, 2019 with respect to Old STERIS (as hereinafter defined).
F2: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), received by the Reporting Person pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the Reporting Person received shares of STERIS in an amount equal to the number of the Reporting Person's cancelled shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"). The Reporting Person's STERIS shares are subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares, except as otherwise required by law. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS.
F3: Represents 30 ordinary share equivalents held on behalf of the Reporting Person under the STERIS Corporation 401(k) Plan as of March 28, 2019.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
STERIS plc
Report date March 28, 2019 · Filed March 28, 2019
Section 16 reporting ended · disclosed 2019-03-28. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary Shares, 10 pence par valueSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 1
1 source rowRow 1 · 2019-03-28 · Disposition to issuer · Disposed 5,898 · Balance 0 F1: All 5,898 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,378 on October 4, 2021 and 2,520 on May 31, 2022. F2: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $114.22 · Expires 2028-05-31 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-03-28 · Disposition to issuer · Disposed 14,932 · Balance 0 F3: This option becomes exercisable as follows: 3,733 on May 31, 2019; 3,733 on June 1, 2020; 3,733 on June 1, 2021 and 3,733 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 14,932 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
Filing footnotes · ownership attribution and instrument terms
F1: All 5,898 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,378 on October 4, 2021 and 2,520 on May 31, 2022.
F2: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS.
F3: This option becomes exercisable as follows: 3,733 on May 31, 2019; 3,733 on June 1, 2020; 3,733 on June 1, 2021 and 3,733 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 14,932 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 31, 2019 Filed Jun 3, 2019 20:39 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (right to buy) · Derivative | 12,828 | $0.00 Strike: $147.05 | $0.00 |
DisclosureSEC source: 0001209191-19-033943 · doc4.xml · derivative · entry 2 deZwaan Michiel · CIK 0001616395 · V.P., Human Resources & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,828 Underlying: Ordinary Shares · 12,828 shares Expires 2029-05-31 F3 · derivative.exercise_date: This option becomes exercisable as follows: 3,207 on June 1, 2020; 3,207 on June 1, 2021; 3,207 on May 31, 2022 and 3,207 on May 31, 2023. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 20:39 UTC | STERIS plc STE · Entity 3228 | GrantOrdinary Shares | 2,224 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-033943 · doc4.xml · nonDerivative · entry 1 deZwaan Michiel · CIK 0001616395 · V.P., Human Resources & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,122 F1 · shares: All 2,224 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,224 on May 31, 2023. F2 · balance_after: All 8,122 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,378 on October 4, 2021; 2,520 on May 31, 2022 and 2,224 on May 31, 2023. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:02 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (right to buy) · Derivative | 14,932 | Not disclosed Strike: $114.22 | Not disclosed |
DisclosureSEC source: 0001209191-19-021600 · doc4.xml · derivative · entry 2 deZwaan Michiel · CIK 0001616395 · V.P., Human Resources & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,932 Underlying: Ordinary Shares · 14,932 shares Expires 2028-05-31 F3 · price: This option becomes exercisable as follows: 3,733 on May 31, 2019; 3,733 on June 1, 2020; 3,733 on June 1, 2021 and 3,733 on May 31, 2022. This option was received under the Scheme in exchange for an option to purchase 14,932 STERIS ordinary shares for $114.22 per share, subject to the same terms and conditions as the original Old STERIS stock option. F3 · derivative.exercise_date: This option becomes exercisable as follows: 3,733 on May 31, 2019; 3,733 on June 1, 2020; 3,733 on June 1, 2021 and 3,733 on May 31, 2022. This option was received under the Scheme in exchange for an option to purchase 14,932 STERIS ordinary shares for $114.22 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:02 UTC | STERIS plc STE · Entity 3228 | GrantOrdinary Shares | 5,898 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-021600 · doc4.xml · nonDerivative · entry 1 deZwaan Michiel · CIK 0001616395 · V.P., Human Resources & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,898 F1 · shares: All 5,898 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,378 on October 4, 2021 and 2,520 on May 31, 2022. F2 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS") received by the reporting person pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received shares of STERIS in an amount equal to the number of the reporting person's cancelled shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"). The reporting person's STERIS shares are subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. F1 · balance_after: All 5,898 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,378 on October 4, 2021 and 2,520 on May 31, 2022. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 09:46 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 14,932 | Not disclosed Strike: $114.22 | Not disclosed |
DisclosureSEC source: 0001209191-19-021558 · doc4.xml · derivative · entry 2 deZwaan Michiel · CIK 0001616395 · V.P., Human Resources & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 14,932 shares Expires 2028-05-31 F3 · price: This option becomes exercisable as follows: 3,733 on May 31, 2019; 3,733 on June 1, 2020; 3,733 on June 1, 2021 and 3,733 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 14,932 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F3 · derivative.exercise_date: This option becomes exercisable as follows: 3,733 on May 31, 2019; 3,733 on June 1, 2020; 3,733 on June 1, 2021 and 3,733 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 14,932 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 09:46 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerOrdinary Shares, 10 pence par value | 5,898 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-021558 · doc4.xml · nonDerivative · entry 1 deZwaan Michiel · CIK 0001616395 · V.P., Human Resources & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: All 5,898 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,378 on October 4, 2021 and 2,520 on May 31, 2022. F2 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. Read SEC document |
| March 28, 2019 Filed Jun 27, 2019 20:32 UTC Amendment | STERIS plc STE · Entity 3228 | GrantOrdinary Shares | 30 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-039273 · doc4a.xml · nonDerivative · entry 1 deZwaan Michiel · CIK 0001616395 · V.P., Human Resources & CHRO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 30 F1 · shares: The Reporting Person failed to report ordinary share equivalents held in the STERIS Corporation 401k Plan. A corresponding failure to report was made in the Reporting Person's Form 4 filing made March 28, 2019 with respect to Old STERIS (as hereinafter defined). F2 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), received by the Reporting Person pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the Reporting Person received shares of STERIS in an amount equal to the number of the Reporting Person's cancelled shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"). The Reporting Person's STERIS shares are subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares, except as otherwise required by law. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. F3 · ownership.nature: Represents 30 ordinary share equivalents held on behalf of the Reporting Person under the STERIS Corporation 401(k) Plan as of March 28, 2019. Read SEC document |
| May 31, 2018 Filed Jun 1, 2018 16:50 UTC | STERIS plc STE · Entity 158792 | GrantEmployee Stock Option (right to buy) · Derivative | 14,932 | $0.00 Strike: $114.22 | $0.00 |
DisclosureSEC source: 0001209191-18-034724 · doc4.xml · derivative · entry 2 deZwaan Michiel · CIK 0001616395 · V.P., Human Resources & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,932 Underlying: Ordinary Shares · 14,932 shares Expires 2028-05-31 F3 · derivative.exercise_date: This option becomes exercisable as follows: 3,733 on May 31, 2019; 3,733 on June 1, 2020; 3,733 on June 1, 2021 and 3,733 on May 31, 2022. Read SEC document |
| May 31, 2018 Filed Jun 1, 2018 16:50 UTC | STERIS plc STE · Entity 158792 | GrantOrdinary Shares, 10 pence par value | 2,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-034724 · doc4.xml · nonDerivative · entry 1 deZwaan Michiel · CIK 0001616395 · V.P., Human Resources & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,898 F1 · shares: All 2,520 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,520 on May 31,2022. F2 · balance_after: All 5,898 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,378 on October 4, 2021 and 2,520 on May 31, 2022. Read SEC document |
| October 02, 2017 Filed Oct 3, 2017 16:46 UTC | STERIS plc STE · Entity 158792 | GrantOrdinary Shares, 10 pence par value | 3,378 | $88.80 | $299,966.40 |
DisclosureSEC source: 0001209191-17-055182 · doc4.xml · nonDerivative · entry 1 ZWAAN MICHIEL DE · CIK 0001616395 · V.P., Human Resources & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,378 F1 · balance_after: All 3,378 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,378 on October 4, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.